Hepatitis B Trial, Recruiting (NCT07170748)

Hepatitis B Trial, Recruiting NCT07170748 Sponsor: MagIA Diagnostics Condition: Hepatitis B

Printed from Voxsanity (voxsanity.com.au) — NCT07170748 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis B

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be willing and able to give your agreement (consent) to take part in the study
You may be eligible if you have a blood sample (serum or plasma) that tests positive for HIV-1 antibodies, HIV-2 antibodies, Hepatitis C antibodies, Hepatitis B surface antigen, or syphilis markers (TPHA and/or VDRL)
You may also be eligible if you have a blood sample that tests negative for those conditions, and you are a blood donor, a hospital patient, or someone attending a clinic
You may also be eligible if you are from a vulnerable group such as people who use drugs or people in prison, and your sample tests negative (confirm with trial site)
You may be eligible if you have a negative blood sample and are pregnant
You may be eligible if you have a negative blood sample and have or have had certain other infections, including Hepatitis A or E, tuberculosis, gonorrhoea, chlamydia, influenza, or COVID-19
You may be eligible if you have a negative blood sample and have high levels of certain substances in your blood, such as IgG (an immune protein), rheumatoid factor, cholesterol, bilirubin, or triglycerides (confirm with trial site)
You may be eligible if you have a negative blood sample and have been diagnosed with cancer

Who may not be able to join:

People under 18 years of age are not eligible to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07170748

Sponsor: MagIA Diagnostics

Phase: Not Applicable

Status: Recruiting

Condition: Hepatitis B

More information: https://clinicaltrials.gov/study/NCT07170748

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be willing and able to give your agreement (consent) to take part in the study
You may be eligible if you have a blood sample (serum or plasma) that tests positive for HIV-1 antibodies, HIV-2 antibodies, Hepatitis C antibodies, Hepatitis B surface antigen, or syphilis markers (TPHA and/or VDRL)
You may also be eligible if you have a blood sample that tests negative for those conditions, and you are a blood donor, a hospital patient, or someone attending a clinic
You may also be eligible if you are from a vulnerable group such as people who use drugs or people in prison, and your sample tests negative (confirm with trial site)
You may be eligible if you have a negative blood sample and are pregnant
You may be eligible if you have a negative blood sample and have or have had certain other infections, including Hepatitis A or E, tuberculosis, gonorrhoea, chlamydia, influenza, or COVID-19
You may be eligible if you have a negative blood sample and have high levels of certain substances in your blood, such as IgG (an immune protein), rheumatoid factor, cholesterol, bilirubin, or triglycerides (confirm with trial site)
You may be eligible if you have a negative blood sample and have been diagnosed with cancer

Who may not be able to join:

People under 18 years of age are not eligible to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

MagIA Diagnostics

Registry

ClinicalTrials.gov

Start date

29 July 2025

Est. completion

1 April 2026

Where this trial is recruiting

Côte d’Ivoire Kenya

Primary endpoints

Performance evaluation of MagIA H3S in detection of HIV-Ab, HBAg, HCV-Ab and TP-Ab

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov